GAS5 and cancer: Nonetheless, the study has limitations, including reliance on a single cell line and the assessment of direct apoptosis only.<h4>Conclusion</h4>These findings highlight a complex interplay between GAS5, CD20, rituximab, and cellular pathways, underscoring the significance of understanding these interactions to enhance cancer therapy outcomes.